Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Currently submitted to: JMIR mHealth and uHealth

Date Submitted: Oct 25, 2023
Date Accepted: Apr 30, 2024

The final, peer-reviewed published version of this preprint can be found here:

Cardiac Health Assessment Using a Wearable Device Before and After Transcatheter Aortic Valve Implantation: Prospective Study

Eerdekens R, Zelis J, ter Horst H, Crooijmans C, van 't Veer M, Keulards D, Kelm M, Archer G, Kuehne T, Brueren G, Wijnbergen I, Johnson N, Tonino P

Cardiac Health Assessment Using a Wearable Device Before and After Transcatheter Aortic Valve Implantation: Prospective Study

JMIR Mhealth Uhealth 2024;12:e53964

DOI: 10.2196/53964

PMID: 38832585

PMCID: 11185971

Prospective Cardiac Health Assessment using a wearable device before and after TAVI

  • Rob Eerdekens; 
  • Jo Zelis; 
  • Herman ter Horst; 
  • Caia Crooijmans; 
  • Marcel van 't Veer; 
  • Danielle Keulards; 
  • Marcus Kelm; 
  • Gareth Archer; 
  • Titus Kuehne; 
  • Guus Brueren; 
  • Inge Wijnbergen; 
  • Nils Johnson; 
  • Pim Tonino

ABSTRACT

Background:

Due to the aging of the population, the prevalence of aortic valve stenosis will increase dramatically in upcoming years. Consequently Transcatheter Aortic Valve Implantation (TAVI) procedures will also expand worldwide. Optimal selection of patients who benefit with improved symptoms and prognosis is key since TAVI is not without risk. Currently we are not able to adequately predict functional outcome after TAVI. Quality of life measurement tools and traditional functional assessment tests do not always agree and can depend on factors unrelated to heart disease. Activity tracking using wearable devices might provide a more comprehensive assessment.

Objective:

Identify objective parameters (e.g. change in heart rate) from a wearable device (the Philips Health Watch) associated with improvement after TAVI for severe aortic stenosis.

Methods:

100 patients undergoing routine TAVI wore a Philips Health Watch for one week before and after the procedure. Watch data were analyzed offline: 97 before and 75 after TAVI.

Results:

Parameters like the total number of steps and activity time did not change, in contrast to improvements in the six-minute walking test (6MWT) and physical limitation domain of a questionnaire (transformed WHOQOL-BREF).

Conclusions:

These findings in an elderly TAVI population show that watch-based parameters like the number of steps do not change after TAVI, unlike traditional 6MWT and QoL assessments that do improve. Basic wearable device parameters might be less appropriate for measurement of treatment effects from TAVI.


 Citation

Please cite as:

Eerdekens R, Zelis J, ter Horst H, Crooijmans C, van 't Veer M, Keulards D, Kelm M, Archer G, Kuehne T, Brueren G, Wijnbergen I, Johnson N, Tonino P

Cardiac Health Assessment Using a Wearable Device Before and After Transcatheter Aortic Valve Implantation: Prospective Study

JMIR Mhealth Uhealth 2024;12:e53964

DOI: 10.2196/53964

PMID: 38832585

PMCID: 11185971

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.